Home/Filings/4/0001415889-23-006359
4//SEC Filing

Kovacs Shane William Charles 4

Accession 0001415889-23-006359

CIK 0001750284other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 4:30 PM ET

Size

5.1 KB

Accession

0001415889-23-006359

Insider Transaction Report

Form 4
Period: 2023-04-06
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
  • Purchase

    Common Stock

    2023-04-06+10,000396,197 total
Footnotes (2)
  • [F1]The weighted average purchase price for the transaction reported was $3.4173, and the range of prices were between $3.375 and $3.42. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
  • [F2]Includes 5,000 shares acquired under the issuer's Employee Stock Purchase Plan.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001579397

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:30 PM ET
Size
5.1 KB